Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Raphaël Laoun"'
Publikováno v:
Inflammatory Intestinal Diseases, Pp 1-1 (2023)
Introduction: High-strength mesalazine formulations play an important role in providing a convenient option to increase the dose in ulcerative colitis (UC) patients and therefore avoiding the switch to another therapeutic class. Higher doses of mesal
Externí odkaz:
https://doaj.org/article/70f95bd183ff402486d0bf9bdddd46d3
Autor:
Xavier Hébuterne, Stephan R Vavricka, Helen C Thorne, Lara MacKenzie-Smith, Raphaël Laoun, Johan Burisch
Publikováno v:
Inflammatory Intestinal Diseases, Pp 1-1 (2023)
Introduction: Patient adherence is a major challenge for the successful management of any chronic disease, and ulcerative colitis (UC) is no exception. Patient adherence is closely related to patient preference of medication and formulation used. Aim
Externí odkaz:
https://doaj.org/article/1442727c37d54ca7a2290f44dea1ebb4
Autor:
Marla C. Dubinsky, Rory Collins, Maria T. Abreu, Vipul Jairath, James D. Lewis, James Lindsay, Miriam Merad, Siew Ng, Remo Panaccione, Julian Panes, Bruce Sands, Corey A. Siegal, Siddarth Singh, Severine Vermeire, Vineet Ahuja, Matthieu Allez, Ashwin Ananthakrishnan, Willem Bemelman, Jonathan Braun, Jean-Frederic Colombel, Silvio Danese, Geert D’Haens, André D’Hoore, Axel Dignass, Iris Dotan, Miguel Angel Gassul, Anne Griffiths, Jonas Halfvarson, Stephen Hanauer, Paulo Kotze, Ioannis Koutroubakis, Edward Loftus, Edouard Louis, Fernando Magro, Gerassimos Mantzaris, Jean-Yves Mary, Dermot McGovern, Pia Munkholm, Colm O’Morain, Yves Panis, Laurent Peyrin-Biroulet, Cosimo Prantera, Zhihua Ran, Britta Siegmund, Mark Silverberg, Eduard Stange, Stephan Targan, Curt Tysk, Simon Travis, Morton Vatn, Yesus Yamamoto-Furusho, Janske Aarts, Brihad Abhyankar, Harris Ahmad, Richard Aranda, Vipin Arora, Jalil Benjacoub, Sofie Berg, Robin Besuyen, Daniela Bojic, Valerio Carriero, Fabio Cataldi, Laurence D’Agay, Silvia Delgado-Aros, Paul Giannasca, Kavitha Goyal, Roland Greinwald, Savion Gropper, Shunsuke Kageyama, Raphaël Laoun, Barrett Levesque, Trevor Lissoos, Irene Modesto, Ralf Mohrbacher, Ralph Mueller, April Naegeli, Snehal Naik, Deanne Nguyen, Wojciech Niezychowski, Caitriona O’Brien, Irina Odnoletkova, Alessandra Oortwijn, Kun K.T. Park, Waldemar Radziszewski, Leonardo Salese, Johannes Spleiss, Andrea Stancati, Amanda Tatro, Jennifer Thompson, Robert Hofmann, Javier Zambrano, Wen Zhou, Ellen Zigmont
Publikováno v:
International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) 2021, ' Challenges and Opportunities in IBD Clinical Trial Design ', Gastroenterology, vol. 161, no. 2, pp. 400-404 . https://doi.org/10.1053/j.gastro.2021.03.065
Gastroenterology, 161(2), 400-404. W.B. Saunders Ltd
Gastroenterology, 161(2), 400-404. W.B. Saunders Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c272afd267a593087dd98af0c866112
https://curis.ku.dk/portal/da/publications/challenges-and-opportunities-in-ibd-clinical-trial-design(b6b0ec30-7f3c-4165-a128-1f4e70ec620b).html
https://curis.ku.dk/portal/da/publications/challenges-and-opportunities-in-ibd-clinical-trial-design(b6b0ec30-7f3c-4165-a128-1f4e70ec620b).html